Vicore Pharma to Participate in Upcoming Healthcare Conferences

• Wells Fargo Healthcare Conference
  Location: Encore Boston Harbor, Boston, Mass.
  Format: 1×1 meetings
  Participation Date: Tuesday, September 8, 2026
  Participant: Ahmed Mousa, Chief Executive Officer

• Cantor Global Healthcare Conference
  Location: Waldorf Astoria New York, New York, N.Y.
  Format: Fireside chat and 1×1 meetings
  Fireside Chat Date and Time: Friday, September 11, 2026, 9:45–10:15 AM ET
  Webcast: Link
  Participant: Ahmed Mousa, Chief Executive Officer

For more information, please contact:

Hans Jeppsson, CFO, +46 70 553 14 65, hans.jeppsson@vicorepharma.com

About Vicore Pharma

Vicore Pharma is a clinical-stage biopharmaceutical company unlocking the potential of a new class of drugs with disease-modifying potential in respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). The company’s lead program, buloxibutid, is an oral small molecule angiotensin II type 2 receptor agonist, which has received Orphan Drug and Fast Track designation from the United States Food and Drug Administration and is currently being investigated in the global 52-week Phase 2b ASPIRE trial in IPF. Vicore Pharma is publicly listed on Nasdaq Stockholm (VICO) and Nasdaq US (VCRE). www.vicorepharma.com